{"filings":[{"id":972517,"accession_number":"0001628280-26-042165","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2026-06-10T20:02:30+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"UFP Technologies appoints Mitchell Rock as CEO, Ryan Stafford as General Counsel & SVP HR","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mitchell C. Rock appointed CEO and joins Board effective June 4, 2026.","Ryan Stafford named General Counsel, SVP HR, and Secretary, succeeding retiring Chris Litterio.","Board size increased from 7 to 8; Rock fills new director seat.","Stafford receives $400K base salary, 50% bonus target, and $650K equity grant (50% RSUs, 50% PSUs).","CFO Ronald Lataille granted $1M stock unit award (4,454 units) vesting over ~3 years."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":919676,"accession_number":"0001628280-26-041647","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2026-06-08T20:44:45+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies provides updated investor presentation for June 2026","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Updated investor presentation furnished under Item 7.01; no material financial updates disclosed.","Presentation includes forward-looking statements and risk factors; no specific guidance changes.","No new financial results, strategic transactions, or leadership changes announced in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":879876,"accession_number":"0001628280-26-041108","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2026-06-05T16:37:40+00:00","items":["5.07"],"status":"ready","headline":"UFP Technologies stockholders elect all director nominees, approve say-on-pay and auditor at 2026 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All seven director nominees elected: R. Jeffrey Baily, Thomas Oberdorf, Marc Kozin, Daniel C. Croteau, Cynthia L. Feldmann, Joseph John Hasset, Symeria Hudson.","Advisory vote on executive compensation approved with 5,971,694 for, 664,037 against, 43,334 abstained (89.1% of votes cast).","Ratification of Grant Thornton LLP as independent auditor for 2026 approved with 7,029,294 for, 69,957 against, 2,934 abstained (99.0% of votes cast).","Broker non-votes were 423,120 on director election and say-on-pay; none on auditor ratification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":667999,"accession_number":"0001628280-26-038097","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2026-05-26T20:17:19+00:00","items":["5.02"],"status":"ready","headline":"UFP Technologies GC Christopher Litterio plans retirement after transition (notified May 19, 2026)","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Christopher P. Litterio, General Counsel, Secretary, and Senior Vice President of Human Resources, informed UFP Technologies on May 19, 2026 of his intention to retire after a transition period.","No specific retirement date or replacement has been announced.","He will remain with the company during the transition, per the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99717,"accession_number":"0001628280-26-029906","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2026-05-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies Q1 net income $17.5M, revenue up 4.1% to $154.2M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP EPS $2.24, adjusted EPS $2.48; net income up 1.8% YoY from $17.2M.","Medical sales grew 5.9% to $143.4M; non-medical fell 15% to $10.8M.","Robotic surgery (+7%), patient surfaces (+11%), interventional (+15%) led growth.","Two new Dominican Republic facilities in Q2 for robotic surgery and safe patient handling capacity.","Start-up costs for four ramping programs and AJR E-Verify labor inefficiencies weighed on margins."],"consensus_eps_estimate":null,"consensus_eps_actual":2.24,"consensus_revenue_estimate":null,"consensus_revenue_actual":154202000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115880,"accession_number":"0001628280-26-012667","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2026-02-27T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies files updated investor presentation; no material changes disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Filed 8-K furnishing updated investor presentation under Item 7.01.","Presentation dated March 2026; no specific financial or operational updates provided.","Intended for use in meetings with investors and other interested parties."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115879,"accession_number":"0001628280-26-011154","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"UFP Tech extends supply pact with Intuitive Surgical to 2029, boosts min volumes","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Amendment No. 27 extends Manufacturing Supply Agreement term by two years, now through Dec 31, 2029.","Materially increases annual minimum volumes for the Company's largest program under the agreement in 2028 and 2029.","Adds a new program to the Supply Agreement, expanding the scope of products supplied to Intuitive Surgical.","Includes volume-based pricing tied to minimum purchase thresholds and cost-sharing provisions; specific terms redacted as confidential.","WSUT's fleet of 22 PSVs (19 Brazilian-built) brings Tidewater's total global OSV fleet to 213 and expands Brazil presence to 28 vessels."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115878,"accession_number":"0001628280-26-011152","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["1.05"],"status":"ready","headline":"UFP Technologies detects cyber incident; data exfiltrated, systems mostly restored","summary_kind":"llm","event_type":"cyber","confidence":"high","bullets":["On Feb 14, 2026, UFP detected unauthorized access; third party removed and access restored in all material respects.","Incident impacted many IT systems, including billing and label making; operations continued across all material respects.","Certain company data appears stolen or destroyed; extent of sensitive or personal data exfiltration still under investigation.","Company expects insurance to reimburse significant portion of containment and remediation direct costs.","As of filing, incident not materially impacting financial systems, operations, or financial condition; investigation ongoing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115877,"accession_number":"0001628280-26-011150","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies reports record 2025 sales of $602.8M, EPS $8.75","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $68.3M (+15.8% YoY); adjusted net income $76.1M (+12.7%).","Sales $602.8M (+19.5% YoY); medical sales up 23.2%, non-medical down 11.5%.","GAAP EPS $8.75; adjusted EPS $9.76 vs $8.68 in 2024.","Q4 sales $148.9M (+3.4%); Q4 GAAP EPS $2.25, adjusted $2.44.","AJR labor inefficiencies $6.3M full-year ($1.2M Q4); expects resolution."],"consensus_eps_estimate":null,"consensus_eps_actual":8.75,"consensus_revenue_estimate":null,"consensus_revenue_actual":602797000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115876,"accession_number":"0001628280-26-008183","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2026-02-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"UFP Technologies appoints Mitchell C. Rock as CEO effective June 4, 2026; base salary $700k","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mitchell C. Rock appointed CEO effective June 4, 2026; base salary $700k, annual bonus target up to 100% of base.","Rock receives one-time RSU grant of $650k (3yr vesting) and annual LTI target of $1.75M for 2026, increasing to $3M from 2027.","Executive severance agreement provides 18 months base salary for non-CIC termination, 2x (salary + bonus) plus equity acceleration for CIC termination within 6 months.","Board approved base salary increases for other NEOs: Lataille $505k, Litterio $400.5k, Holt $400k.","Retiring CEO Bailly receives $5.1M stock unit award fully vesting June 4, 2027, and his salary reduces to $600k as Executive Chairman."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132293,"accession_number":"0001628280-25-054605","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-12-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies posts updated investor presentation; no specific financial disclosures in excerpt","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Updated investor presentation (Exhibit 99.1) released for meetings starting December 2025.","Excerpt provided does not contain new financial data, guidance, or material business changes.","Presentation likely covers business strategy, but full details are not included in this filing text."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132292,"accession_number":"0001628280-25-054603","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-12-02T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"UFP Technologies CEO Bailly to retire June 2026; President Rock to succeed","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["R. Jeffrey Bailly will retire as CEO effective June 4, 2026, after 31 years as CEO.","President Mitchell Rock will become CEO and join the Board on that date.","Bailly will serve as Executive Chairman for one year to facilitate transition.","Under Bailly, revenue grew ~20x, profitability and market cap grew >150x.","Rock has served as President since Feb 2024 and has 25+ years with the company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132291,"accession_number":"0001628280-25-048260","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-11-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies Q3 EPS flat at $2.11; sales up 6.5% but organic sales flat due to labor issue","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net income $16.4M ($2.11 diluted EPS), flat YoY; adjusted EPS $2.39.","Sales $154.6M (+6.5% YoY); MedTech up 7.3% to $142.4M; non-medical down 2.7%.","Gross margin fell to 27.7% from 28.6% due to ~$3M incremental labor cost at Illinois AJR facility; absent that, would have been 29.6%.","Organic sales flat; over $8M in orders unfulfilled due to labor eligibility review at AJR; Q4 impact expected to be significantly less.","Two new robotic surgery programs on track for commercial production by year-end; CEO expects significant 2026+ revenue."],"consensus_eps_estimate":null,"consensus_eps_actual":6.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":453882000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148876,"accession_number":"0001171843-25-005547","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-08-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies files updated investor presentation under Regulation FD","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Furnished investor presentation under Item 7.01; no financial results disclosed.","Presentation includes forward-looking statements; no specific guidance changes reported.","Ticker UFPT; no new material operational data available from filing excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148875,"accession_number":"0001171843-25-005027","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies Q2 2025: Record net income $17.2M; sales up 37% YoY; completed two acquisitions","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income of $17.2M ($2.21 diluted EPS) vs $13.6M ($1.75) in Q2 2024; adjusted EPS $2.50 (+27%).","Sales of $151.2M, up 37.2% YoY; organic growth 4.9%; MedTech +46%, Advanced Components -20%.","Gross margin 28.8% (down from 30.0%) from ~$1.2M labor costs at AJR facility due to E-Verify protocols.","Completed acquisitions of Universal Plastics & Engineering and Techno Plastics Industries in Q2.","Adjusted EBITDA $31.8M, up 33.2% YoY; YTD adjusted EBITDA $62.1M, up 39.1%."],"consensus_eps_estimate":null,"consensus_eps_actual":4.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":151176000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148874,"accession_number":"0001171843-25-004519","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-07-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies acquires UNIPEC ($7.5M) and TPI ($4.5M) to expand medical device film and molding capabilities","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["UNIPEC acquired for $7.5M cash; ~3.75x adj. EBITDA; $5M revenue, $2M EBITDA.","TPI acquired for $4.5M cash; ~4.5x adj. EBITDA; $10M revenue, $1M EBITDA.","Acquisitions expand thin film (UNIPEC) and thermoplastic molding (TPI) capabilities for implantable and surgical devices.","Funded with available cash and borrowings under existing credit facility.","Both companies serve Class III implantable medical device OEMs."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167773,"accession_number":"0001171843-25-003809","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-06-10T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies furnishes investor presentation; no material new data disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Presentation filed under Regulation FD for use in investor meetings.","No specific financial figures, guidance updates, or operational milestones provided.","Presentation appears to be an updated overview without material changes from prior communications."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167772,"accession_number":"0001171843-25-003753","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-06-06T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"UFP Technologies reports annual meeting results; all director nominees elected and proposals approved","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders elected all seven director nominees; highest vote count for Symeria Hudson at 6,311,434 for.","Advisory vote on executive compensation passed with 5,684,666 for vs 799,852 against.","Advisory vote favored 1-year frequency for future say-on-pay votes (5,996,792 votes for 1 year).","Ratification of Grant Thornton LLP as auditor for 2025 approved with 6,445,924 for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167771,"accession_number":"0001171843-25-002859","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies reports record Q1: revenue $148.1M (+41%), net income $17.2M (+35%), EPS $2.21","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $148.1M vs $105.0M (+41.1%); MedTech sales up 50.4% to $135.4M.","GAAP diluted EPS $2.21 vs $1.64; adjusted EPS $2.47 vs $1.77; adjusted EBITDA $30.2M (+45.9%).","MedTech organic growth 5.4% despite 6% Robotic Surgery decline; overall organic growth 2.3%.","Exclusive manufacturing agreement with second-largest customer for Safe Patient Handling through June 2030; Dominican Republic expansion.","Closed small fold-in acquisition (former sister company of AJR); balance sheet strengthened with debt paydown."],"consensus_eps_estimate":null,"consensus_eps_actual":2.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":148148000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167770,"accession_number":"0001171843-25-002025","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-04-04T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"UFP Technologies enters exclusive supply agreements with Stryker; manufacturing to move to Dominican Republic","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["AJR Enterprises subsidiary signs two exclusive supply agreements with Sage Products (Stryker) for manufacturing rights.","March 31 agreement: 42-month exclusive term starting Jan 1, 2026; Stryker purchases 100% of requirements for certain products.","March 26 agreement amends prior deal: ~63-month term effective April 24, 2024, with similar exclusivity and manufacturing commitments.","UFP agrees to purchase equipment and transfer manufacturing to Dominican Republic over two years; Stryker provides payment for equipment.","Stryker may cease exclusivity if UFP fails regulatory/quality requirements; price reductions apply as production transfers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185044,"accession_number":"0001171843-25-001597","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-03-20T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"UFP Technologies' MedTech COO Steve Cardin resigns, effective March 28","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Steve Cardin, VP and COO of MedTech business, resigned effective March 28, 2025.","No replacement has been announced by the company.","No reason for the resignation was disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185043,"accession_number":"0001171843-25-001061","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-02-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies reports record 2024 revenue of $504.4M, adj. EPS $8.68, up 31%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full-year net income $59.0M (+31.3%); adjusted net income $67.6M (+32.5%); GAAP EPS $7.58, adj. EPS $8.68.","Q4 sales $144.1M (+41.9%); Q4 adj. net income $19.2M (+51.6%); Q4 adj. EPS $2.46.","MedTech sales grew 48.6% in Q4 and 30.2% for full year; gross margin improved to 29.1% from 28.1%.","Adjusted EBITDA for 2024 reached $107.3M, up 39.1% from $77.2M in 2023.","CEO cites acquisitions performing ahead, Dominican Republic expansion, and two major programs launching H2 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":7.58,"consensus_revenue_estimate":null,"consensus_revenue_actual":504421000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185042,"accession_number":"0001171843-25-000897","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-02-18T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"UFP Technologies approves FY2025 executive base salary increases and stock unit awards","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Bailly base salary raised to $789,000; President Rock to $525,000; CFO Lataille to $485,000, effective Jan 1, 2025.","CEO Bailly granted 11,515 threshold stock units plus 5,758 target and 5,758 exceptional units.","CEO 2025 cash bonus target set at $828,450 (105% of base salary); max $1,656,900.","Other NEOs' cash bonus targets set at 40%-65% of base salary, with discretionary adjustment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":201637,"accession_number":"0001171843-24-006275","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies Q3 net income up 40% to $16.4M, sales up 44% to $145.2M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income rose 40% to $16.4M vs $11.7M YoY; adjusted net income up 46.5% to $18.6M.","Sales increased 44% to $145.2M; organic sales growth of 9.7% driven by robotic surgery and infection prevention markets.","Acquisitions accretive to EPS by ~$0.17 after absorbing $3.1M in interest expense; gross margin 28.6% despite $1.1M in purchase accounting costs.","Adjusted EBITDA up 61.4% to $31.2M; nine-month adjusted EBITDA $75.9M up 26% YoY.","Medical market sales up 52.2% to $132.6M; aerospace and defense up 27.9% year-to-date."],"consensus_eps_estimate":null,"consensus_eps_actual":5.49,"consensus_revenue_estimate":null,"consensus_revenue_actual":360351000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217628,"accession_number":"0001171843-24-004926","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2024-08-26T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies posts updated investor presentation; no specific new facts disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company issued an updated investor presentation (August 2024) for use in meetings with investors and other parties.","The presentation is furnished under Regulation FD; no financial results or material events are announced in this filing.","No changes to earnings guidance, dividends, or corporate strategy were disclosed in the 8-K or accompanying exhibit.","Given the limited information provided, confidence in identifying material news is low."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217627,"accession_number":"0001171843-24-004922","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2024-08-26T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies acquires AQF Medical for €43M; 12.3x EBITDA multiple","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price €43.0M cash; multiple ~12.3x adjusted EBITDA for 12 months ended June 30, 2024.","AQF Medical is a custom-engineered foam and thermoplastic components manufacturer for medical devices, based in Ireland with JV in Singapore.","Fourth acquisition by UFP in recent months, expanding European manufacturing and enabling Asian market support.","CEO R. Jeffrey Bailly highlights shared clients and AQF's leadership team as key to international growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217626,"accession_number":"0001171843-24-004404","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2024-08-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies Q2 net income $13.6M ($1.75 EPS), revenue up 10% to $110.2M; acquires three firms","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $13.6M ($1.75 diluted EPS) vs $11.9M ($1.55) in Q2 2023, up 14.0%.","Q2 revenue $110.2M (+10.1% YoY), driven by robotic surgery and infection prevention markets.","Completed three acquisitions (Marble Medical, AJR Enterprises, Welch Fluorocarbon) adding ~$90M revenue and $20M EBITDA.","New $275M credit facility; pro-forma leverage ~1.8x post-acquisitions.","Gross margin improved to 30.0% from 29.6%; SG&A increased to 12.6% of sales."],"consensus_eps_estimate":null,"consensus_eps_actual":3.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":110177000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217625,"accession_number":"0001171843-24-003980","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2024-07-16T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies completes two bolt-on acquisitions: Welch Fluorocarbon ($34.6M) and Marble Medical ($4.5M)","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Welch Fluorocarbon acquired for $34.6M cash plus up to $6M earnout based on 2024-2026 EBITDA targets; ~11.5x adjusted EBITDA.","Marble Medical acquired for $4.5M cash plus up to $0.5M earnout based on 2024-2025 sales targets; ~4.5x adjusted EBITDA.","Welch has ~$15M annual sales; specializes in thin-film thermoformed implantable medical device components.","Marble has ~$5M annual sales; specializes in adhesive-based medical components and single-use devices.","Both acquisitions closed July 16, 2024; expand MedTech product capabilities in thin films and adhesives."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217624,"accession_number":"0001171843-24-003738","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2024-07-01T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"UFP Technologies acquires AJR Enterprises for $110M; finances with new $275M credit facility","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price $110M cash; AJR generated ~$75M sales and ~$18.3M adjusted EBITDA TTM ended Mar 31, 2024.","AJR is a medical device contract manufacturer specializing in single-use safe patient handling devices.","Transaction financed under new $275M credit agreement ($125M term loan + $150M revolver), maturing 2029.","At close, $115M term loan and $35M revolver drawn; $114M revolver availability remains.","Credit facility interest at SOFR + 1.25%-2.25% based on leverage ratio."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":237529,"accession_number":"0001171843-24-003384","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2024-06-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies files updated investor presentation, no specific financial data disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Presentation intended for use in investor meetings and speeches.","No specific financial data or material changes disclosed in the filing text.","Confidence is low as exhibit contents are not fully provided.","Presentation covers business overview but details not extracted."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":237528,"accession_number":"0001171843-24-003340","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2024-06-07T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"UFP Technologies 2024 annual meeting results: directors elected, say-on-pay approved, auditor ratified","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All seven director nominees elected; R. Jeffrey Bailly received 6,218,977 votes for, 342,484 withheld.","Non-binding advisory resolution on executive compensation approved: 6,151,911 for, 391,181 against, 18,369 abstained.","Ratification of Grant Thornton LLP as independent auditor for FY 2023: 6,945,594 for, 56,773 against, 1,211 abstained.","Broker non-votes of 442,117 on director elections and say-on-pay; none on auditor ratification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":237527,"accession_number":"0001171843-24-002424","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies Q1 net income up 30% to $12.7M; EPS $1.64; sales $105M (+7.4%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Diluted EPS of $1.64 vs $1.27 in Q1 2023; net income $12.7M vs $9.7M.","Revenue $105.0M, up 7.4% YoY; medical market sales $90.0M (+7.4%); other markets $15.0M (+7.4%).","Operating income grew 24% to $15.9M; adjusted EBITDA $20.7M (+6.5%); gross margin 28.6% (down from 29.4%).","CEO cites growth in robotic surgery and infection prevention; Mexico sales up 47%; Dominican Republic expansion complete.","Balance sheet with ~$34M debt; active acquisition pipeline with multiple projects in due diligence."],"consensus_eps_estimate":null,"consensus_eps_actual":1.64,"consensus_revenue_estimate":null,"consensus_revenue_actual":105009000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":255069,"accession_number":"0001171843-24-001413","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2024-03-18T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"UFP Technologies enters amended supply deal with Intuitive Surgical; estimates $500M revenue over initial term","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amended manufacturing supply agreement with Intuitive Surgical SARL, effective Jan 1, 2024, for a four-year initial term.","Intuitive agrees to purchase majority of certain products on a semi-exclusive basis with volume-based pricing.","UFP estimates approximately $500 million in revenue over the initial term if volume thresholds are met.","Agreement automatically renews for one-year terms; either party may terminate for breach or non-renewal."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":255068,"accession_number":"0001171843-24-000970","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2024-02-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies reports record 2023; EPS up 7% to $5.83, sales +13.1%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2023 net sales $400.1M (+13.1% YoY); net income $44.9M ($5.83 diluted EPS) vs $41.8M ($5.45).","Q4 sales $101.5M (+11.2%); net income $11.6M ($1.51) vs $8.5M ($1.10) year ago.","MedTech sales grew 21% to $346.4M; adjusted operating income +37.9% to $61.3M.","Adjusted net income per diluted share up 41.0% for full year; adjusted EBITDA $77.3M.","Added 70% capacity for robotic surgery with new clean rooms in Ireland, Costa Rica, Dominican Republic."],"consensus_eps_estimate":null,"consensus_eps_actual":5.83,"consensus_revenue_estimate":null,"consensus_revenue_actual":400072000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":255067,"accession_number":"0001171843-24-000679","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2024-02-08T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"UFP Technologies appoints Mitchell Rock as President; CEO Bailly remains Chairman and CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mitchell Rock appointed President effective Feb 6, 2024; previously President of UFP MedTech.","Rock's base salary raised to $500,000 and granted 5,134 stock unit awards with time and performance vesting.","CEO R. Jeffrey Bailly retains Chairman & CEO roles; receives 5,175 threshold/target/exceptional stock unit awards.","CFO Ronald Lataille base salary increased to $460,000 effective Jan 1, 2024; granted 2,185 threshold stock units.","CEO Bailly's 2024 cash bonus target set at $705,000 (base salary); maximum $1.41 million under 2003 Incentive Plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":272531,"accession_number":"0001171843-23-007303","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2023-11-28T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies posts updated investor presentation for November 2023","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company furnished presentation materials for use in meetings with investors.","No financial results, guidance changes, or new strategic initiatives disclosed in the filing.","Presentation contains forward-looking statements and cautionary notes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":272530,"accession_number":"0001171843-23-006922","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2023-11-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies Q3 adjusted net income up 13.8% to $11.9M; sales $100.8M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales Q3 $100.8M (+3.9% YoY); YTD $298.6M (+13.7%). Organic growth 5.6% in Q3.","Adjusted net income Q3 $11.9M (+13.8%); YTD $35.8M (+44.4%). Adjusted EBITDA $19.3M.","Medical sales Q3 $87.1M (+6.8%); gross margin improved to 27.5% from 26.3% YoY.","CEO notes customer inventory softness short-term; expansion in Dominican Republic (+40k sq ft) and Costa Rica (+15k sq ft) to boost capacity.","GAAP net income Q3 $11.7M down from $19.5M due to prior-year gain on Molded Fiber sale."],"consensus_eps_estimate":null,"consensus_eps_actual":4.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":100784000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":289361,"accession_number":"0001171843-23-005386","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2023-08-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies furnishes updated investor presentation; no new financial data disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Filed 8-K to furnish updated investor presentation under Regulation FD dated August 2023.","Presentation replaces prior version from March 2022; slide titles show only welcome slides.","No specific financial or operational updates extracted from the filing; presentation content not fully included.","Ticker UFPT, presentation used for meetings with investors and other interested parties."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":289360,"accession_number":"0001171843-23-005006","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2023-08-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies posts record Q2: net income $11.9M, EPS $1.55, sales $100M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $11.9M ($1.55 diluted EPS) vs $8.9M ($1.17) in Q2 2022, up 34%.","Sales $100.0M (+6.0% YoY); MedTech sales +15.9%; organic sales +13% excluding divested Molded Fiber.","Gross margin improved to 29.6% from 25.8%; adjusted operating income up 41.6% to $17.3M.","Acquisitions (DAS, Contech, Advant Medical) performing ahead of expectations; new Tijuana facility profitable.","YTD net income $21.6M ($2.81 EPS) vs $13.8M ($1.81); sales $197.8M (+19.4% YoY)."],"consensus_eps_estimate":null,"consensus_eps_actual":2.81,"consensus_revenue_estimate":null,"consensus_revenue_actual":100037000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310168,"accession_number":"0001171843-23-003892","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2023-06-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies updates investor presentation; no material disclosures","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company furnished an updated investor presentation for use in June 2023 meetings.","No specific financial numbers, guidance changes, or strategic initiatives are disclosed.","Presentation furnished under Regulation FD and not incorporated by reference."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310167,"accession_number":"0001171843-23-003887","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2023-06-13T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"UFP Technologies: stockholders approve charter amendment adding officer exculpation; elect 7 directors","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Stockholders approved amendment to certificate of incorporation to add officer exculpation per Delaware law and remove Series A Preferred references.","Seven directors elected: Bailly, Oberdorf, Kozin, Croteau, Feldmann, Hassett, Hudson.","Non-binding advisory vote on executive compensation passed: 5,105,276 for, 521,459 against.","Ratification of Grant Thornton LLP as independent auditor for FY2023: 6,159,636 for, 57,886 against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310166,"accession_number":"0001171843-23-003867","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2023-06-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies posts updated investor presentation; no material changes disclosed","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Filed updated presentation materials for investor meetings on June 12, 2023.","Presentation dated June 2023 replaces prior March 2022 version; no specific financial updates or guidance mentioned.","No new material events, earnings, or strategic announcements included."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310165,"accession_number":"0001171843-23-002774","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2023-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies Q1 net income $9.7M ($1.27 EPS), revenue up 37% to $97.8M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Medical market sales surged 59.5% to $83.8M, led by 112% growth in robotic surgery.","Gross margin improved 530 bps to 29.4% from 24.1% a year ago, boosting profitability.","Operating income rose 101.9% to $12.8M; adjusted operating income up 120.3% to $15.7M.","EBITDA grew 64.8% to $15.5M; adjusted EBITDA jumped 78.7% to $19.5M.","Company absorbed $2.85M contingent consideration charge for DAS acquisition, reflects strong performance."],"consensus_eps_estimate":null,"consensus_eps_actual":1.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":97753000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310164,"accession_number":"0001171843-23-002478","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2023-04-24T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"UFP Technologies board adopts Second Amended and Restated Bylaws effective April 24, 2023","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Amendments update stockholder nomination procedures to comply with SEC Universal Proxy Rules (Rule 14a-19).","Adds new information requirements for stockholder proposals and director nominations.","Requires nominating stockholders to comply with Universal Proxy Rules and use a proxy card color other than white.","Removes requirement to make stockholder list available during meetings per recent DGCL changes.","Full text of Second A&R Bylaws filed as Exhibit 3.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":328825,"accession_number":"0001171843-23-001786","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2023-03-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies releases updated investor presentation for March 2023","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Presentation covers business overview and strategy for investor meetings.","No financial results or material updates disclosed in the filing.","Presentation dated March 2023; available as Exhibit 99.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":328824,"accession_number":"0001171843-23-001594","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2023-03-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies reports record 2022 revenue $353.8M, EPS $5.45 (+160% YoY)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full-year 2022 revenue $353.8M (+71.5% YoY); net income $41.8M ($5.45 diluted EPS) vs $15.9M ($2.09) in 2021.","Q4 2022 revenue $91.2M (+61.9% YoY); net income $8.5M ($1.10 diluted EPS) vs $3.2M ($0.42) in Q4 2021.","Medical market sales grew 116% to $286.2M for the year; acquisitions (DAS, Contech, Advant Medical) performed above expectations.","Organic base business grew 18.6% in 2022; adjusted operating income $44.5M vs $21.6M in 2021.","Ended year with ~$55M debt; management bullish on synergies and new investments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":328823,"accession_number":"0001171843-23-001068","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2023-02-21T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"UFP Technologies raises CEO base salary to $680k, grants $300k special bonus and stock options","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Base salary increases effective Jan 1, 2023: CEO Bailly $680k, CFO Lataille $440k, SVP Litterio $355k, SVP Rock $440k, VP Cardin $325k.","Special discretionary cash bonus of $300k to CEO Bailly for 2022 exceptional financial performance.","Stock options to CEO Bailly: 7,766 shares at $111.54, vesting 50% on Mar 1, 2024 and 50% on Mar 1, 2025.","Stock unit awards to executives with threshold, target, exceptional levels based on adjusted operating income, vesting over 3 years.","2023 CEO bonus plan target $680k, max $1.36M; other executives target 40-50% of base salary."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":346488,"accession_number":"0001171843-22-007487","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2022-11-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies files updated investor presentation with no new financial data","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Presentation furnished under Item 7.01; no material financial metrics or guidance disclosed.","Presentation intended for investor meetings and conferences; forward-looking statements included.","Only title slide visible in exhibit; substantive content not provided in filing text.","No changes to previously reported financials or business outlook indicated."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":346487,"accession_number":"0001171843-22-007130","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2022-11-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies reports record Q3: EPS $2.56 vs $0.50, sales up 91% to $97M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $19.5M ($2.56 diluted EPS) vs $3.8M ($0.50) in Q3 2021; sales $97.0M, up 91.2% YoY.","Medical market sales surged 152% to $81.6M; organic sales grew 21.7%, organic operating income up 36.6%.","Results include $15.6M gain on sale of Molded Fiber Technology and $3.3M earnout charge for DAS acquisition.","Gross margin improved to 26.3% from 23.7%; year-to-date net income $33.3M, up from $12.7M."],"consensus_eps_estimate":null,"consensus_eps_actual":4.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":262555000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":362869,"accession_number":"0001171843-22-006155","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2022-09-20T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies files 8-K with updated investor presentation; no specific financial updates disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company furnished updated investor presentation materials dated September 21, 2022.","Presentation used for meetings with investors and other audiences; no new financial guidance.","No material changes or transactions were disclosed in the filing or presentation excerpt.","Presentation content is not provided in detail in the exhibit; confidence is limited."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":1697871262.7545092,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-09-20T23:59:59+00:00|362869"}